Quality of care evaluation in non-functioning pituitary adenoma with chiasm compression: visual outcomes and timing of intervention clinical recommendations based on a systematic literature review and cohort study.
Adenoma
/ complications
Cohort Studies
Decompression, Surgical
Female
Hemianopsia
/ etiology
Humans
Male
Middle Aged
Optic Chiasm
Pituitary Neoplasms
/ complications
Quality of Health Care
Recovery of Function
Severity of Illness Index
Time Factors
Treatment Outcome
Tumor Burden
Vision Disorders
/ etiology
Visual Acuity
Visual Field Tests
Non-functioning pituitary adenoma
Optic chiasm compression
Pituitary tumor
Transsphenoidal surgery
Visual fields
Visual outcome
Journal
Pituitary
ISSN: 1573-7403
Titre abrégé: Pituitary
Pays: United States
ID NLM: 9814578
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
pubmed:
19
5
2020
medline:
4
5
2021
entrez:
19
5
2020
Statut:
ppublish
Résumé
Surgery in patients with non-functioning pituitary macroadenomas (NFMA) is effective in ameliorating visual function. The urgency for decompression, and preferred timing of surgery related to the preoperative severity of dysfunction is unknown. Systematic review for evidence to provide clinical guidance for timing of surgical decompression of the optic chiasm, and a cohort study of 30 NFMA patients, in whom mean deviation (MD), and severity of visual dysfunction was assessed. Systematic review 44 studies were included with a total of 4789 patients. Postoperatively, visual field defects improved in 87.0% of patients, stabilized in 12.8% and worsened in 1.0%. Specific protocols regarding timing of surgery were not reported. Only seven studies (16.7%) reported on either the duration of visual symptoms, or diagnostic, or treatment delay. Cohort study 30 NFMA patients (50% female, 60 eyes, mean age 58.5 ± 14.8 years), had a median MD of - 5.3 decibel (IQR - 3.1 to - 10.1). MD was strongly correlated with clinical severity (r = - 0.94, P < 0.0001), and were used for severity of defects cut-off values: (1) normal > - 2 dB, (2) mild - 2 dB to - 4 dB, (3) moderate - 4 to - 8 dB, (4) severe - 8 to - 17 dB, (5) very severe < - 17 dB. Surgical decompression is highly effective in improving visual function. Uniform, quantitative grading of visual dysfunction was lacking. MD is a promising quantitative outcome measure. We provide recommendations for the evaluation of timing of surgery, considering severity of visual impairment, which will need further validation based on expert clinical practice.
Identifiants
pubmed: 32419072
doi: 10.1007/s11102-020-01044-0
pii: 10.1007/s11102-020-01044-0
pmc: PMC7316692
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
417-429Commentaires et corrections
Type : ErratumIn
Références
J Clin Endocrinol Metab. 2006 Dec;91(12):4769-75
pubmed: 16968795
Neurosurgery. 2015 Jan;76(1):42-52; discussion 52-3
pubmed: 25255271
Surg Neurol. 2004 May;61(5):436-45; discussion 445-6
pubmed: 15120215
J Clin Endocrinol Metab. 2006 May;91(5):1796-801
pubmed: 16507632
Arq Neuropsiquiatr. 2013 May;71(5):307-12
pubmed: 23689408
J Neurooncol. 2011 Mar;102(1):129-38
pubmed: 20730474
Neurosurg Rev. 2012 Jul;35(3):369-78; discussion 378-9
pubmed: 22080165
Clin Endocrinol (Oxf). 1999 Jul;51(1):109-13
pubmed: 10469480
Surg Neurol. 1999 Oct;52(4):380-5
pubmed: 10555844
Eur J Endocrinol. 2013 Oct 21;169(6):735-42
pubmed: 23999643
World Neurosurg. 2018 Aug;116:e960-e967
pubmed: 29857216
Am J Ophthalmol. 1989 Aug 15;108(2):130-5
pubmed: 2757094
Mayo Clin Proc. 1999 Jul;74(7):661-70
pubmed: 10405694
J Endocrinol Invest. 1998 May;21(5):284-90
pubmed: 9648049
Exp Clin Endocrinol Diabetes. 2004 Jun;112(6):323-7
pubmed: 15216450
World Neurosurg. 2019 Jun;126:e706-e712
pubmed: 30849556
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Eur J Endocrinol. 2019 Oct;181(4):375-387
pubmed: 31340199
J R Soc Med. 1991 Mar;84(3):140-3
pubmed: 2013893
World Neurosurg. 2018 Dec;120:e326-e332
pubmed: 30144606
Clin Neurol Neurosurg. 2013 Dec;115(12):2514-20
pubmed: 24262138
World Neurosurg. 2015 Dec;84(6):1572-8
pubmed: 26341428
Curr Opin Ophthalmol. 1995 Apr;6(2):46-51
pubmed: 10150857
World Neurosurg. 2015 Jul;84(1):48-57
pubmed: 25731792
World Neurosurg. 2012 Mar-Apr;77(3-4):533-9
pubmed: 22120331
World Neurosurg. 2016 Jan;85:185-92
pubmed: 26344636
Cancers (Basel). 2019 Oct 21;11(10):
pubmed: 31640258
Am J Ophthalmol. 1983 Aug;96(2):200-8
pubmed: 6881243
Skull Base Surg. 1999;9(2):109-17
pubmed: 17171126
Exp Clin Endocrinol Diabetes. 2011 May;119(5):314-9
pubmed: 21264809
J Endocrinol Invest. 2015 Nov;38(11):1191-7
pubmed: 26215449
World Neurosurg. 2017 Oct;106:315-321
pubmed: 28676462
Clin Neurol Neurosurg. 2012 Sep;114(7):885-90
pubmed: 22326130
J Neurol Neurosurg Psychiatry. 1989 Jan;52(1):31-7
pubmed: 2709034
Neurosurgery. 2005 Jun;56(6):1222-33; discussion 1233
pubmed: 15918938
Ophthalmology. 2008 Mar;115(3):560-5
pubmed: 18082887
AJNR Am J Neuroradiol. 2006 Feb;27(2):250-4
pubmed: 16484385
World Neurosurg. 2016 May;89:442-53
pubmed: 26902781
J Neurosurg. 1986 May;64(5):713-9
pubmed: 3701419
Acta Neurochir (Wien). 2004 Jan;146(1):27-35
pubmed: 14740262
Pituitary. 2010;13(1):68-77
pubmed: 19697135
Br J Neurosurg. 1991;5(2):129-33
pubmed: 1863373
Eur J Endocrinol. 2019 Nov;181(5):R185-R197
pubmed: 31416048
Pituitary. 2007;10(1):61-5
pubmed: 17318437
Neuroendocrinology. 2012;96(4):333-42
pubmed: 22687984
Eye (Lond). 2002 Nov;16(6):731-8
pubmed: 12439668
Pituitary. 2017 Oct;20(5):489-498
pubmed: 28884415
J Clin Neurosci. 2011 Jan;18(1):71-5
pubmed: 20851609
Surg Neurol. 2002 Jun;57(6):380-90; discussion 390
pubmed: 12176196
Acta Neurochir (Wien). 1989;100(1-2):50-5
pubmed: 2816535
J Neurosurg. 2015 Jul;123(1):31-8
pubmed: 25839926
Arq Neuropsiquiatr. 2015 Sep;73(9):764-9
pubmed: 26352495
Q J Med. 1989 May;71(265):417-27
pubmed: 2602541
J Neurosurg. 2011 Sep;115(3):518-27
pubmed: 21639700
Rhinology. 2015 Dec;53(4):308-16
pubmed: 26301431
Ned Tijdschr Geneeskd. 2008 Apr 5;152(14):792-6
pubmed: 18491820
Acta Neurochir (Wien). 2014 Dec;156(12):2233-43; discussion 2243
pubmed: 25174805
Surg Neurol Int. 2015 Nov 26;6:179
pubmed: 26674325
Int J Ophthalmol. 2017 Nov 18;10(11):1742-1750
pubmed: 29181320
J Neurosurg. 2006 Jun;104(6):884-91
pubmed: 16776331
Prog Retin Eye Res. 2019 Nov;73:100765
pubmed: 31202890
J Neurosurg. 2012 Feb;116(2):283-9
pubmed: 21740118
Eur J Endocrinol. 2007 Feb;156(2):217-24
pubmed: 17287411
Acta Neurochir (Wien). 2011 Apr;153(4):831-42
pubmed: 21267606